Dialytic dose in pediatric continuous renal replacement therapy patients

被引:1
|
作者
Ricci, Zaccaria [1 ]
Guzzi, Francesco [2 ]
Tuccinardi, Germana [3 ,4 ,5 ]
Romagnoli, Stefano [5 ,6 ]
机构
[1] Bambino Gesu Pediat Hosp, IRCCS, Dept Cardiol & Cardiac Surg, Pediat Cardiac Intens Care Unit, Rome, Italy
[2] Meyer Childrens Hosp, Nephrol & Dialysis Unit, Florence, Italy
[3] Meyer Childrens Hosp, Dept Pediat Neuroanesthesia NeuroICU, Florence, Italy
[4] Meyer Childrens Hosp, Pediat Trauma Ctr, Florence, Italy
[5] Univ Florence, Dept Hlth Sci, Sect Anesthesiol & Intens Care, Florence, Italy
[6] Azienda Osped Univ Careggi, Dept Anesthesia & Intens Care, Florence, Italy
关键词
Renal replacement therapy; Child; Renal dialysis; CONTINUOUS VENOVENOUS HEMODIAFILTRATION; CRITICALLY-ILL CHILDREN; DYSFUNCTION SYNDROME; CLINICAL-COURSE; MORTALITY; DIALYSIS; ADEQUACY; INFANTS; CRRT; KG;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Although universally recognized as a crucial component of renal replacement therapy (RRT), dialytic dose has not been investigated in children with renal failure, differently from the adult population. Consequently, clear indications on the adequacy of continuous RRT in pediatric population is currently missing and wide variations in clinical practice exist worldwide. Fluid balance ha's been identified as a key factor in affecting outcomes these patients. Nonetheless, the concept and the precise evaluation of the dialytic dose for continuous pediatric RRT seems crucial, especially in light of the small body surface area of neonates and infants that might result into a difficult dose calculation. The present review clearly demonstrates that dialytic dose in pediatric RRT has been underestimated by scientific literature. Nowadays, the absence of any specific dedicated prospective study and the tendency to overlook theoretical basis of pediatric dialytic dose have led to the absence of a standard prescription: worldwide clinical practice ranges from very high doses to lower ones, also depending on different ways of estimating patients' sizes and solutes' volume of distribution. Large structured studies are warranted in order to define a reference dialytic dose for critically ill children, capable to cope an adequate solute control to gentle and safe treatments.
引用
收藏
页码:366 / 373
页数:8
相关论文
共 50 条
  • [1] Delivered dose for pediatric continuous renal replacement therapy
    Lion, R.
    Srivaths, P.
    Swartz, S.
    Angelo, J.
    Braun, M.
    Arikan, Akcan A.
    [J]. PEDIATRIC NEPHROLOGY, 2016, 31 (07) : 1206 - 1207
  • [2] Pediatric Continuous Renal Replacement Therapy for "40 Years of Continuous Renal Replacement Therapy"
    Goldstein, Stuart L.
    [J]. 40 YEARS OF CONTINUOUS RENAL REPLACEMENT THERAPY, 2018, 194 : 146 - 154
  • [3] Pediatric Continuous Renal Replacement Therapy
    Ricci, Zaccaria
    Goldstein, Stuart L.
    [J]. ACUTE KIDNEY INJURY - FROM DIAGNOSIS TO CARE, 2016, 187 : 121 - 130
  • [4] Dose in continuous renal replacement therapy
    Claure-Del Granado, Rolando
    [J]. GACETA MEDICA DE MEXICO, 2018, 154 : S40 - S47
  • [5] Continuous renal replacement therapy in critically ill pediatric patients
    Zobel, G
    Ring, E
    Rodl, S
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) : S28 - S34
  • [6] Special issues with continuous renal replacement therapy in pediatric patients
    Jenkins, R
    [J]. SEMINARS IN DIALYSIS, 1996, 9 (02) : 179 - 183
  • [7] Demographic characteristics of pediatric continuous renal replacement therapy: A report of the prospective pediatric continuous renal replacement therapy registry
    Symons, Jordan M.
    Chua, Annabelle N.
    Somers, Michael J. G.
    Baum, Michelle A.
    Bunchman, Timothy E.
    Benfield, Mark R.
    Brophy, Patrick D.
    Blowey, Douglas
    Fortenberry, James D.
    Chand, Deepa
    Flores, Francisco X.
    Hackbarth, Richard
    Alexander, Steven R.
    Mahan, John
    McBryde, Kevin D.
    Goldstein, Stuart L.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (04): : 732 - 738
  • [8] Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy
    Andrews, Lauren
    Benken, Scott
    Tan, Xing
    Wenzler, Eric
    [J]. BMC NEPHROLOGY, 2021, 22 (01)
  • [9] Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy
    Lauren Andrews
    Scott Benken
    Xing Tan
    Eric Wenzler
    [J]. BMC Nephrology, 22
  • [10] The Evolution of Pediatric Continuous Renal Replacement Therapy
    Garzotto, Francesco
    Zanella, Monica
    Ronco, Claudio
    [J]. NEPHRON CLINICAL PRACTICE, 2014, 127 (1-4): : 172 - 175